Pfizer

Kosmos is an AI scientist from Edison Scientific, a commercial spinout of FutureHouse, announced on 5 November 2025. It reads literature, analyses data and generates hypotheses over a long run focused on one research objective, and every conclusion can be traced to specific lines of code or passages of literature. Edison Scientific charges $200 a